Immunity and inflammation in atherosclerosis

D Wolf, K Ley - Circulation research, 2019 - Am Heart Assoc
There is now overwhelming experimental and clinical evidence that atherosclerosis is a
chronic inflammatory disease. Lessons from genome-wide association studies, advanced in …

Generation and biological activities of oxidized phospholipids

VN Bochkov, OV Oskolkova, KG Birukov… - Antioxidants & redox …, 2010 - liebertpub.com
Glycerophospholipids represent a common class of lipids critically important for integrity of
cellular membranes. Oxidation of esterified unsaturated fatty acids dramatically changes …

Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis

Y Döring, HD Manthey, M Drechsler, D Lievens… - Circulation, 2012 - Am Heart Assoc
Background—Inflammation has been closely linked to auto-immunogenic processes in
atherosclerosis. Plasmacytoid dendritic cells (pDCs) are specialized to produce type-I …

Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis

R Klingenberg, M Lebens, A Hermansson… - … , and vascular biology, 2010 - Am Heart Assoc
Objective—Atherosclerosis is an inflammatory disease. Autoimmune responses to low-
density lipoproteins (LDL) contribute to its progression, whereas immunization with LDL may …

Phosphorylcholine-targeting immunization reduces atherosclerosis

G Caligiuri, J Khallou-Laschet, M Vandaele… - Journal of the American …, 2007 - jacc.org
Objectives: The present study evaluated the effect of phosphorylcholine (PC) immunization
on the extent of experimental atherosclerosis. Background: Immunization against oxidized …

Vaccination strategies and immune modulation of atherosclerosis

J Nilsson, GK Hansson - Circulation Research, 2020 - Am Heart Assoc
Adaptive as well as innate immune responses contribute to the development of
atherosclerosis. Studies performed in experimental animals have revealed that some of …

The autoimmune origin of atherosclerosis

C Blasi - Atherosclerosis, 2008 - Elsevier
Atherosclerosis is a chronic inflammatory disease. Many studies and observations suggest
that it could be caused by an immune reaction against autoantigens at the endothelial level …

Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine

M Wigren, D Kolbus, P Dunér… - Journal of internal …, 2011 - Wiley Online Library
Wigren M, Kolbus D, Dunér P, Ljungcrantz I, Söderberg I, Björkbacka H, Fredrikson GN,
Nilsson J.(Malmö University Hospital, Lund University; Malmö University, Malmo; Sweden) …

Atheroprotective vaccination with MHC-II restricted peptides from ApoB-100

K Tse, A Gonen, J Sidney, H Ouyang… - Frontiers in …, 2013 - frontiersin.org
Background: Subsets of CD4+ T-cells have been proposed to serve differential roles in the
development of atherosclerosis. Some T-cell types are atherogenic (T-helper type 1), while …

Vaccination to modulate atherosclerosis

T Kimura, K Tse, A Sette, K Ley - Autoimmunity, 2015 - Taylor & Francis
Atherosclerosis is a chronic inflammatory disease of the artery wall. Adaptive immunity plays
a key role in the pathogenesis of atherosclerosis. Recently, modulation of the immune …